PART I Unless the context otherwise requires, for purposes of this section, the terms we, us, our, our Company, the Company or Senti refer to Senti Biosciences, Inc. and its subsidiaries. Overview We are a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with our gene circuit platform technologies for patients living with incurable diseases. Our mission is to create a new generation of smarter medicines that outsmart complex diseases using novel ...
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001628280-26-021580 | EDGAR | 114K words |
| 2025-03-20 | 2024-12-31 | 0001854270-25-000042 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0001854270-24-000029 | EDGAR | — |
| 2023-03-22 | 2022-12-31 | 0001854270-23-000033 | EDGAR | — |
| 2022-03-07 | 2021-12-31 | 0001193125-22-067994 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001628280-25-052125 | EDGAR | 73K words |
| 2025-08-07 | 2025-06-30 | 0001854270-25-000090 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001854270-25-000065 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001854270-24-000116 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001854270-24-000101 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001854270-24-000052 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001854270-23-000129 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001854270-23-000105 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001854270-23-000064 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001854270-22-000043 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001854270-22-000019 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001193125-22-151676 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-01 | 0001628280-26-022824 | EDGAR | 1K words |
| 2026-03-27 | 0001628280-26-021578 | EDGAR | — |
| 2026-03-19 | 0001628280-26-019789 | EDGAR | — |
| 2025-12-09 | 0001628280-25-055953 | EDGAR | — |
| 2025-11-13 | 0001628280-25-052083 | EDGAR | — |
| 2025-08-07 | 0001854270-25-000088 | EDGAR | — |
| 2025-07-18 | 0001854270-25-000077 | EDGAR | — |
| 2025-06-30 | 0001854270-25-000073 | EDGAR | — |
| 2025-06-18 | 0001854270-25-000069 | EDGAR | — |
| 2025-05-06 | 0001854270-25-000062 | EDGAR | — |
104 total filings indexed. 77 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001854270 |
| Ticker | SNTI |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.sentibio.com |
| Listed | 2022-06-09 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report